Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other Non-Current Assets: 2021-2024

Historic Other Non-Current Assets for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $14.1 million.

  • Prime Medicine's Other Non-Current Assets fell 2.64% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 2.64%. This contributed to the annual value of $14.1 million for FY2024, which is 4.19% up from last year.
  • Latest data reveals that Prime Medicine reported Other Non-Current Assets of $14.1 million as of FY2024, which was up 4.19% from $13.5 million recorded in FY2023.
  • Over the past 5 years, Prime Medicine's Other Non-Current Assets peaked at $14.1 million during FY2024, and registered a low of $13.1 million during FY2021.
  • Over the past 3 years, Prime Medicine's median Other Non-Current Assets value was $13.5 million (recorded in 2023), while the average stood at $13.7 million.
  • Data for Prime Medicine's Other Non-Current Assets shows a peak YoY climbed of 4.19% (in 2024) over the last 5 years.
  • Over the past 4 years, Prime Medicine's Other Non-Current Assets (Yearly) stood at $13.1 million in 2021, then grew by 2.83% to $13.5 million in 2022, then remained steady at $13.5 million in 2023, then increased by 4.19% to $14.1 million in 2024.